Interestingly, EVs derived from cancer-associated fibroblasts (CAFs) contain miR-423-5p, and these CAF-EVs promote taxane resistance in prostate cancer by targeting gremlin-2 (GREM2) to activate the transforming growth factor beta (TGFβ) pathway [85]. Here, GREM2 is linked to prostate carcinoma.